Project Number 290102-WELLINGTON-2009 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2009 View Full Project Details for The therapeutic potential of ABCA1 and apoE for Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) c. ApoE, Lipids and Lipoprotein Receptors Researcher and Organization Principal Investigator WELLINGTON, CHERYL LEA Principal Investigator First Name CHERYL Principal Investigator Last Name WELLINGTON Awardee Organization University of British Columbia Contact PI Country Canada Project Detail Funding Opportunity Announcement General RFP FY Overall Cost $75,000 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
